Medication info

Bonisense Injection (Pre-filled) (Sodium Hyaluronate)

Prescription medicationInjectionsInjection
Ingredient · strength
Sodium Hyaluronate›10mg / 1mL
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
An injection filled with a colorless, transparent, viscous liquid contained in a colorless, transparent glass tube sealed with rubber stoppers at both ends (part of the pre-filled syringe system)
Packaging
2ml/tube x 3
Approval status
Active

MFDS item code 201901432 · Notified 2019.03.08 · Insurance code 671806991

Summary

Main use
Treatment of knee osteoarthritis and periarthritis of the shoulder
Who receives it
Adults
Adult administration
Usually, adults receive 1 vial once weekly for 3 consecutive weeks into the knee joint or shoulder joint (glenohumeral joint, subacromial bursa, or tendon sheath of the long head of the biceps), but the frequency of administration may be adjusted as appropriate according to symptoms. As this medicine is administered intra-articularly, it must be administered using strict aseptic technique.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of knee osteoarthritis and periarthritis of the shoulder

  • Osteoarthritis of the knee joint
  • pericapsulitis of the shoulder
View approved original text

This medicine is used to treat osteoarthritis of the knee joint and pericapsulitis of the shoulder.

How it is given

Adult administration

Usually, adults receive 1 vial once weekly for 3 consecutive weeks into the knee joint or shoulder joint (glenohumeral joint, subacromial bursa, or tendon sheath of the long head of the biceps), but the frequency of administration may be adjusted as appropriate according to symptoms. As this medicine is administered intra-articularly, it must be administered using strict aseptic technique.

Precautions

This medication should not be used in patients with a history of allergic reactions to its ingredients. Caution should be exercised in patients with allergies to other medications or those with liver dysfunction or a history of liver diseases. Additionally, if there is a skin condition or infection at the injection site, the condition should be assessed before administering this medication. Severe shock symptoms may occur during the use of this medication, so patient status should be closely monitored during administration. If swelling of the face or around the eyes, rashes, hives, or itching appear as allergic symptoms, use should be stopped immediately and appropriate treatment sought. Temporary pain, swelling, redness, warmth, and pressure may occur at the injection site, so these symptoms should be reported to the medical staff. Occasionally, symptoms such as nausea, vomiting, and fever may also appear, requiring attention. If there is severe inflammation in the joint, it is advisable to use this medication after the inflammation subsides, and stabilizing the area after administration can be helpful. This medication should be injected accurately into the joint, and care should be taken to avoid leakage of the drug outside the injection site, as it may cause pain. Aseptic conditions must be maintained during administration, and if symptoms do not improve, it should be administered a maximum of three times and then discontinued. If there is a significant accumulation of joint fluid, it is advisable to remove some fluid before administering the medication, if necessary. This medication is not to be used for intravenous administration or eye-related treatments, and a 22–23 gauge needle is appropriate. Additionally, contact with certain disinfectants may cause the medication to precipitate, so such substances should be avoided. Women who are pregnant or may become pregnant should use this medication cautiously only when the benefits outweigh the risks, and nursing mothers should avoid breastfeeding during treatment. The safety of this medication has not been established in children, so it should only be used cautiously when absolutely necessary. Elderly individuals may have decreased bodily function, so special care is needed during use.

Side effects

Shock symptoms, edema (facial, eyelid, etc.), facial flushing, rash, urticaria, itching, pain (mainly transient pain after administration), swelling, ascites, redness, warmth, severe local pressure sensation, nausea, vomiting, fever

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture, and it is best to store it at room temperature between 1 to 30 degrees Celsius. This way of storage helps to maintain the efficacy of the medication for a long time.

Appearance and packaging

Appearance

An injection filled with a colorless, transparent, viscous liquid contained in a colorless, transparent glass tube sealed with rubber stoppers at both ends (part of the pre-filled syringe system)

Package unit

2ml/tube x 3

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.